发明授权
US07968587B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
有权
四氢环戊二烯[b]吲哚化合物作为雄激素受体调节剂
- 专利标题: Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
- 专利标题(中): 四氢环戊二烯[b]吲哚化合物作为雄激素受体调节剂
-
申请号: US12447693申请日: 2007-11-06
-
公开(公告)号: US07968587B2公开(公告)日: 2011-06-28
- 发明人: Konstantinos Gavardinas , Jonathan Edward Green , Prabhakar Kondaji Jadhav , Donald Paul Matthews
- 申请人: Konstantinos Gavardinas , Jonathan Edward Green , Prabhakar Kondaji Jadhav , Donald Paul Matthews
- 申请人地址: US IN Indianapolis
- 专利权人: Eli Lilly and Company
- 当前专利权人: Eli Lilly and Company
- 当前专利权人地址: US IN Indianapolis
- 代理商 Francis O. Ginah; Alexander Wilson
- 国际申请: PCT/US2007/083745 WO 20071106
- 国际公布: WO2008/063867 WO 20080529
- 主分类号: A61K31/403
- IPC分类号: A61K31/403 ; C07D209/60
摘要:
The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly reduced bones mass, osteoporosis, osteopenia, or reduced muscle mass or strength, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof. X-17142.
公开/授权文献
信息查询